Research Report: Medicare Advantage in 2024 – A Look at Premiums, Deductibles, and MOOP Offerings

The analysis of cost factors for 2024 reflects a conservative approach in Medicare Advantage. Zero-premium plans dominate, with modest growth. Drug deductibles fluctuate, influenced by regulatory changes. MOOP values remain stable, except for the >$6000 segment, which declined.